Minervax AB

MinervaX is a clinical-stage biotechnology company dedicated to making a significant global impact through medical innovation. The organization focuses specifically on developing a state-of-the-art prophylactic vaccine targeting Group B Streptococcus (GBS). Their primary motivation is to prevent adv...